期刊文献+

培美曲塞联合铂类治疗恶性腹膜间皮瘤诊疗分析 被引量:1

Pemetrexed combined with platinum to treat patients with malignant peritoneal mesothelioma
下载PDF
导出
摘要 目的:回顾性分析恶性腹膜间皮瘤(malignant peritoneal mesothelioma,MPM)的临床病理特征,观察培美曲塞联合铂类治疗MPM的疗效。方法:收集确诊为MPM且一线接受培美曲塞联合铂类治疗的21例患者临床资料,回顾性分析并总结其临床、病理特点及疗效。结果:18例检测了CA125的患者中,13例(72.2%)增高。病理类型为上皮型的有19例,为肉瘤型/双相型的有2例。所有患者均接受了培美曲塞联合铂类的化疗方案,有效率为23.8%,疾病控制率为85.7%,全组中位生存时间为26个月。结论:MPM发病率低、恶性程度高,大部分患者会出现CA125升高,以培美曲塞为基础的化疗有助于延长晚期患者的生存。 Objective:The clinical and pathological characteristics of malignant peritoneal mesothelioma(MPM) were retrospectively analyzed and to observe the efficacy of combination of pemetrexed combined with platinum in the treatment of MPM.Methods:The clinical data of 21 patients with MPM who received pemetrexed combined with platinum in first-line therapy were collected,and their clinical pathological characteristics and efficacy were retrospectively analyzed and summarized.Results:Of the 18 patients who tested for CA125,13(72.2%) increased.There were 19 epithelioid patterns and 2 sarcomatoid/mixed patterns.Pemetrexed combined with platinum was administered to all patients,the response rate was 23.8% and disease control rate was 85.7%,the median OS was 26 months.Conclusion:The incidence of MPM is low and it’s very malignant,CA125 is increased in most of patients.Pemetrexed-based chemotherapy could prolong the survival of patients with advanced stage.
作者 刘娟 李智可 勾红峰 朱江 LIU Juan;LI Zhi-ke;GOU Hong-feng;ZHU Jiang(Department of Thoracic Oncology,West China Hospital,Sichuan University,Chengdu 610041,Sichuan,China;Department of Abdominal Oncology,West China Hospital,Sichuan University,Chengdu 610041,Sichuan,China)
出处 《川北医学院学报》 CAS 2019年第1期88-91,共4页 Journal of North Sichuan Medical College
关键词 恶性腹膜间皮瘤 疗效 培美曲塞 铂类 Malignant peritoneal mesothelioma Efficacy Pemetrexed Platinum
  • 相关文献

参考文献4

二级参考文献84

  • 1Ordonez NG,黄文斌(摘译),陈洁宇(摘译),潘敏鸿(摘译),周晓军(审校).免疫组织化学和电镜在腹膜间皮瘤和浆液性癌鉴别诊断中的价值[J].临床与实验病理学杂志,2005,21(6):745-745. 被引量:13
  • 2Robinson BWS;Creaney J;Lake R.Mesothelin-family proteins and diagnosis of mesothelioma,2003(12).
  • 3Sugarbaker PH.Peritonectomy procedures,1995.
  • 4Yan,T.D.,Popa,E.,Brun,E.A.Sex difference in diffuse malignant peritoneal mesothelioma. British Journal of Surgery . 2006
  • 5Acherman YI,Welch LS,Bromley CM,et al.Clinical presentation of peritoneal mesothelioma. TUMORI . 2003
  • 6Verwaal VJ,van Ruth S,de Bree E,et al.Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. Journal of Clinical Oncology . 2003
  • 7Glehen O,Kwiatkowski F,Sugarbaker PH,Elias D,Levine EA,De Simone M,Barone R,Yonemura Y,Cavaliere F,Quenet F,Gutman M,Tentes AA,Lorimier G,Bernard JL,Bereder JM,Porcheron J,Gomez-Portilla A,Shen P,Deraco M,Rat P.Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer:a multi-institutional study. Journal of Clinical Oncology . 2004
  • 8Armstrong DK,Bundy B,Wenzel L,et al.Intraperitoneal cisplatin and paclitaxel in ovarian cancer. New England Journal of Medicine, The . 2006
  • 9Glehen O,Mithieux F,Osinsky D,et al.Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study. Journal of Clinical Oncology . 2003
  • 10C. Brigand MD,O. Monneuse MD,F. Mohamed MBChB, MRCS,A. C. Sayag-Beaujard MD,S. Isaac MD,F. N. Gilly MD, PhD,O. Glehen MD, PhD.Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study[J]. Annals of Surgical Oncology . 2006 (3)

共引文献40

同被引文献19

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部